Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.8.107

Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling  

Lee, Hye-Jin (Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University)
Kim, Mi-Yeon (Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University)
Park, Hee-Sae (Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University)
Publication Information
BMB Reports / v.48, no.8, 2015 , pp. 431-437 More about this Journal
Abstract
Notch signaling plays a pivotal role in cell fate determination, cellular development, cellular self-renewal, tumor progression, and has been linked to developmental disorders and carcinogenesis. Notch1 is activated through interactions with the ligands of neighboring cells, and acts as a transcriptional activator in the nucleus. The Notch1 intracellular domain (Notch1-IC) regulates the expression of target genes related to tumor development and progression. The Notch1 protein undergoes modification after translation by posttranslational modification enzymes. Phosphorylation modification is critical for enzymatic activation, complex formation, degradation, and subcellular localization. According to the nuclear cycle, Notch1-IC is degraded by E3 ligase, FBW7 in the nucleus via phosphorylation-dependent degradation. Here, we summarize the Notch signaling pathway, and resolve to understand the role of phosphorylation in the regulation of Notch signaling as well as to understand its relation to cancer. [BMB Reports 2015; 48(8): 431-437]
Keywords
Cancer; Degradation; Kinase; Notch1; Phosphorylation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ and Powell MB (2008) Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 118, 3660-3670   DOI
2 Oswald F, Liptay S, Adler G and Schmid RM (1998) NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18, 2077-2088   DOI
3 Mungamuri SK, Yang X, Thor AD and Somasundaram K (2006) Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res 66, 4715-4724   DOI
4 Zavadil J, Cermak L, Soto-Nieves N and Bottinger EP (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23, 1155-1165   DOI
5 Holt LJ (2012) Regulatory modules: Coupling protein stability to phopshoregulation during cell division. FEBS Lett 586, 2773-2777   DOI
6 O'Neil J, Grim J, Strack P et al (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204, 1813-1824   DOI
7 Ishitani T, Hirao T, Suzuki M et al (2010) Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat Cell Biol 12, 278-285
8 Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271   DOI
9 Ranganathan P, Weaver KL and Capobianco AJ (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11, 338-351   DOI
10 Stylianou S, Clarke RB and Brennan K (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Res 66, 1517-1525   DOI
11 Ma D, Dong X, Zang S et al (2011) Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol 7, 385-391   DOI
12 Luo DH, Zhou Q, Hu SK et al (2014) Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer. Oncol Lett 7, 471-478   DOI
13 Grabher C, von Boehmer H and Look AT (2006) Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6, 347-359   DOI
14 Erbilgin Y, Sayitoglu M, Hatirnaz O et al (2010) Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Dis Markers 28, 353-360   DOI
15 Min SH, Lau AW, Lee TH et al (2012) Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol Cell 46, 771-783   DOI
16 Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U (2008) Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 105, 6392-6397   DOI
17 Welcker M and Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8, 83-93   DOI
18 Fryer CJ, White JB and Jones KA (2004) Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16, 509-520   DOI
19 Li N, Fassl A, Chick J et al (2014) Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol 16, 1080-1091   DOI
20 Espinosa L, Ingles-Esteve J, Aguilera C and Bigas A (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278, 32227-32235   DOI
21 Jin YH, Kim H, Oh M, Ki H and Kim K (2009) Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta. Mol Cells 27, 15-19   DOI
22 Foltz DR, Santiago MC, Berechid BE and Nye JS (2002) Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol 12, 1006-1011   DOI
23 Mo JS, Kim MY, Han SO et al (2007) Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol Cell Biol 27, 5565-5574   DOI
24 Ranganathan P, Vasquez-Del Carpio R, Kaplan FM et al (2011) Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity. J Biol Chem 286, 28844-28857   DOI
25 Fernandez-Martinez J, Vela EM, Tora-Ponsioen M, Ocana OH, Nieto MA and Galceran J (2009) Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J Cell Sci 122, 1574-1583   DOI
26 Song J, Park S, Kim M and Shin I (2008) Down-regulation of Notch-dependent transcription by Akt in vitro. FEBS Lett 582, 1693-1699   DOI
27 Wallberg AE, Pedersen K, Lendahl U and Roeder RG (2002) p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 22, 7812-7819   DOI
28 Fryer CJ, Lamar E, Turbachova I, Kintner C and Jones KA (2002) Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev 16, 1397-1411   DOI
29 Guo S, Liu M and Gonzalez-Perez RR (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta 1815, 197-213
30 Yatim A, Benne C, Sobhian B et al (2012) NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48, 445-458   DOI
31 Zhou S, Fujimuro M, Hsieh JJ et al (2000) SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol 20, 2400-2410   DOI
32 Wu G, Lyapina S, Das I et al (2001) SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21, 7403-7415   DOI
33 Itoh M, Kim CH, Palardy G et al (2003) Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell 4, 67-82   DOI
34 Lai EC, Deblandre GA, Kintner C and Rubin GM (2001) Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev Cell 1, 783-794   DOI
35 Minella AC and Clurman BE (2005) Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 4, 1356-1359   DOI
36 Nash P, Tang X, Orlicky S et al (2001) Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514-521   DOI
37 Jafar-Nejad H, Leonardi J and Fernandez-Valdivia R (2010) Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology 20, 931-949   DOI
38 Logeat F, Bessia C, Brou C et al (1998) The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A 95, 8108-8112   DOI
39 Chillakuri CR, Sheppard D, Lea SM and Handford PA (2012) Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev Biol 23, 421-428   DOI
40 Mumm JS, Schroeter EH, Saxena MT et al (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5, 197-206   DOI
41 Schroeter EH, Kisslinger JA and Kopan R (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-386   DOI
42 Krejci A and Bray S (2007) Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev 21, 1322-1327   DOI
43 McElhinny AS, Li JL and Wu L (2008) Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene 27, 5138-5147   DOI
44 Oswald F, Winkler M, Cao Y et al (2005) RBP-Jkappa/ SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol 25, 10379-10390   DOI
45 Brou C, Logeat F, Lecourtois M et al (1994) Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. Genes Dev 8, 2491-2503   DOI
46 Borggrefe T and Oswald F (2009) The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 66, 1631-1646   DOI
47 Artavanis-Tsakonas S, Rand MD and Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770-776   DOI
48 Bolos V, Grego-Bessa J and de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28, 339-363   DOI
49 Cordle J, Johnson S, Tay JZ et al (2008) A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 15, 849-857   DOI
50 Allenspach EJ, Maillard I, Aster JC and Pear WS (2002) Notch signaling in cancer. Cancer Biol Ther 1, 466-476   DOI
51 Andersson ER, Sandberg R and Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612   DOI
52 Lai EC (2002) Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep 3, 840-845   DOI
53 Foltz DR and Nye JS (2001) Hyperphosphorylation and association with RBP of the intracellular domain of Notch1. Biochem Biophys Res Commun 286, 484-492   DOI
54 Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7, 678-689   DOI
55 Fiuza UM and Arias AM (2007) Cell and molecular biology of Notch. J Endocrinol 194, 459-474   DOI
56 Chiang MY, Xu ML, Histen G et al (2006) Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol Cell Biol 26, 6261-6271   DOI
57 Espinoza I and Miele L (2013) Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. Cancer Lett 341, 41-45   DOI
58 Marignol L, Rivera-Figueroa K, Lynch T and Hollywood D (2013) Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol 10, 405-413   DOI
59 Kong D, Banerjee S, Ahmad A et al (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5, e12445   DOI
60 Palomero T, Sulis ML, Cortina M et al (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13, 1203-1210   DOI